Currently Carinopharm market and distribute Enoximone in the UK but are actively developing new products for the UK marketplace.

Enoximone (Perfan) is a phosphodiesterase III inhibitor indicated for the treatment of congestive heart failure, typically where cardiac output is reduced and filling pressures increased, in patients who require intravenous therapy and who can be closely monitored.